Incannex Healthcare Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Incannex Healthcare Inc. (IXHL) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Operating Activities
Net Income-46.89-18.46-48.81-10.27-8.530.00
Depreciation & Amortization0.250.100.090.000.000.00
Stock Based Compensation2.618.932.151.010.450.00
Change in Working Capital6.78-6.4535.83-13.600.000.00
Change in Accounts Receivable5.580.000.00-0.060.160.00
Change in Inventory0.000.000.000.000.140.00
Change in Accounts Payable1.393.021.100.77-0.220.00
Change in Other Working Capital-0.19-9.470.00-0.412.910.00
Other Operating Activities24.740.030.00-0.412.910.00
Net Cash from Operating Activities-12.51-15.85-10.75-8.81-5.190.00
Investing Activities
Capital Expenditures-0.01-0.28-0.320.000.000.01
Acquisitions0.000.000.000.000.030.00
Net Cash from Investing Activities-0.01-0.28-0.320.000.020.01
Financing Activities
Debt Repayment-1.310.00-0.040.000.00-0.07
Common Stock Issued47.470.008.1841.189.327.47
Other Financing Activities-24.770.000.000.00-0.070.00
Net Cash from Financing Activities21.400.008.1828.339.327.40
Summary
Effect of Forex Changes on Cash0.31-0.14-0.820.000.000.00
Net Change in Cash9.18-16.12-2.8919.524.153.51
Cash at Beginning of Period5.8622.1225.836.282.710.09
Cash at End of Period15.045.8622.1237.506.853.60
Free Cash Flow-12.52-16.12-11.07-12.81-5.19-3.91